Skip to main content
In stock | Cytotoxic Chemotherapy

Decitabine + Cedazuridine (Oral Fixed-Dose)

Oncology Type Hematologic (MDS/AML)
Drug Class / Mechanism Oral Hypomethylating Agent + Cytidine Deaminase Inhibitor
No Image
Description

Decitabine + Cedazuridine (Oral Fixed-Dose) is classified as an Oral Hypomethylating Agent + Cytidine Deaminase Inhibitor, sourced for use within our Cytotoxic Chemotherapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Cytotoxic Chemotherapy
Oncology Type Hematologic (MDS/AML)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3